Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Lausch

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
British Journal of Pharmacology|December 23, 2025
Cannabigerol reverses mechanical allodynia through α<sub>2A</sub>-adrenergic modulation of thalamocortical signaling in chemotherapy-induced neuropathyQuinn W Wade, Nathan Morris, Diana E Sepulveda, et al.
Cancer Research|August 14, 1999
A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agentsB D Chang, E V Broude, M Dokmanovic, et al.
Current Cancer Drug Targets|November 15, 2006
Oncogene-blocking therapies: new insights from conditional mouse tumor modelsJ G Hengstler, E O Bockamp, M Hermes, et al.
British Journal of Cancer|May 6, 2008
Trastuzumab therapy vs tetracycline controlled ERBB2 downregulation: influence on tumour development in an ERBB2-dependent mouse tumour modelM Hermes, W Schormann, M Brulport, et al.
Journal of Medical Genetics|June 26, 2010
Novel and recurrent TRPV4 mutations and their association with distinct phenotypes within the TRPV4 dysplasia familyJ Dai, O-H Kim, T-J Cho, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
British Journal of Pharmacology|December 23, 2025
Cannabigerol reverses mechanical allodynia through α<sub>2A</sub>-adrenergic modulation of thalamocortical signaling in chemotherapy-induced neuropathyQuinn W Wade, Nathan Morris, Diana E Sepulveda, et al.
Cancer Research|August 14, 1999
A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agentsB D Chang, E V Broude, M Dokmanovic, et al.
Current Cancer Drug Targets|November 15, 2006
Oncogene-blocking therapies: new insights from conditional mouse tumor modelsJ G Hengstler, E O Bockamp, M Hermes, et al.
British Journal of Cancer|May 6, 2008
Trastuzumab therapy vs tetracycline controlled ERBB2 downregulation: influence on tumour development in an ERBB2-dependent mouse tumour modelM Hermes, W Schormann, M Brulport, et al.
Journal of Medical Genetics|June 26, 2010
Novel and recurrent TRPV4 mutations and their association with distinct phenotypes within the TRPV4 dysplasia familyJ Dai, O-H Kim, T-J Cho, et al.
Pageof 2